CPB CAMPBELL'S Co
Food and Kindred Products · Nasdaq · SEC CIK 16732 · Fiscal year ends 08/03
Financial factors as of 2026-08-02 (2026Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY-5.0%
TTM net income YoY-33.1%
TTM EPS YoY-34.8%
Revenue 3-yr CAGR1.4%
Net income 3-yr CAGR-22.3%
Margins
Gross margin28.1%
Operating margin8.7%
Net margin4.1%
FCF margin7.0%
EBITDA margin13.0%
Returns
ROE10.4%
ROA2.6%
ROIC (approx.)6.1%
Asset turnover0.64x
Leverage & solvency
Liabilities / assets73.4%
Debt / equity1.85x
Current ratio0.82x
Interest coverage2.57x
Cash quality & payout
Operating cash flow / net income2.58x
Accruals ratio-4.2%
Payout ratio116.6%
Capex / revenue3.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q4*2026-08-02 | 2026Q32026-05-03 | 2026Q22026-02-01 | 2026Q12025-11-02 | 2025Q4*2025-08-03 | 2025Q32025-04-27 | 2025Q22025-01-26 | 2025Q12024-10-27 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $2.14B | $2.37B | $2.56B | $2.68B | $2.32B | $2.48B | $2.69B | $2.77B |
| Cost of revenue | $1.55B | $1.72B | $1.85B | $1.89B | $1.62B | $1.75B | $1.87B | $1.91B |
| Gross profit | $583.00M | $650.00M | $717.00M | $792.00M | $705.00M | $728.00M | $819.00M | $867.00M |
| R&D expense | $28.00M | $25.00M | $22.00M | $24.00M | $26.00M | $23.00M | $25.00M | $26.00M |
| SG&A expense | $164.00M | $155.00M | $160.00M | $167.00M | $172.00M | $162.00M | $165.00M | $175.00M |
| Operating income | $4.00M | $239.00M | $273.00M | $336.00M | $269.00M | $161.00M | $327.00M | $367.00M |
| Interest expense | $85.00M | $83.00M | $82.00M | $81.00M | $85.00M | $85.00M | $88.00M | $87.00M |
| Pretax income | -$79.00M | $159.00M | $193.00M | $256.00M | $184.00M | $81.00M | $247.00M | $284.00M |
| Income tax | -$21.00M | $35.00M | $48.00M | $62.00M | $39.00M | $15.00M | $74.00M | $66.00M |
| Net income | -$60.00M | $124.00M | $145.00M | $194.00M | $145.00M | $66.00M | $173.00M | $218.00M |
| EBITDA | $111.00M | $344.00M | $375.00M | $435.00M | $375.00M | $270.00M | $437.00M | $476.00M |
| EPS (basic) | — | 0.42 | 0.49 | 0.65 | — | 0.22 | 0.58 | 0.73 |
| EPS (diluted) | — | 0.41 | 0.48 | 0.65 | — | 0.22 | 0.58 | 0.72 |
| Dividends declared per share | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 | 0.37 |
| Weighted avg. shares (diluted) | — | 299.00M | 299.00M | 299.00M | — | 299.00M | 299.00M | 301.00M |
| Balance sheet | ||||||||
| Cash & equivalents | $394.00M | $402.00M | $561.00M | $168.00M | $132.00M | $143.00M | $829.00M | $808.00M |
| Receivables | $517.00M | $552.00M | $671.00M | $768.00M | $541.00M | $668.00M | $711.00M | $840.00M |
| Inventory | $1.61B | $1.45B | $1.36B | $1.50B | $1.42B | $1.29B | $1.29B | $1.41B |
| Current assets | $2.72B | $2.56B | $2.73B | $2.56B | $2.23B | $2.23B | $3.18B | $3.14B |
| PP&E, net | $2.87B | $2.73B | $2.75B | $2.74B | $2.77B | $2.67B | $2.64B | $2.68B |
| Goodwill | $5.32B | $4.99B | $4.99B | $4.99B | $4.99B | $4.99B | $4.99B | $5.06B |
| Intangibles | $4.20B | $4.33B | $4.33B | $4.34B | $4.36B | $4.37B | $4.54B | $4.67B |
| Total assets | $15.65B | $15.14B | $15.35B | $15.18B | $14.90B | $14.83B | $15.91B | $16.11B |
| Current liabilities | $3.34B | $2.95B | $2.69B | $3.13B | $2.91B | $2.85B | $3.41B | $3.46B |
| Short-term debt | $977.00M | $864.00M | $428.00M | $874.00M | $762.00M | $799.00M | $1.18B | $1.21B |
| Long-term debt | $6.16B | $6.15B | $6.65B | $6.10B | $6.09B | $6.10B | $6.50B | $6.71B |
| Total debt | $7.14B | $7.01B | $7.08B | $6.97B | $6.86B | $6.90B | $7.67B | $7.92B |
| Total liabilities | $11.49B | $11.11B | $11.34B | $11.22B | $10.99B | $10.96B | $12.00B | $12.27B |
| Shareholders' equity | $3.85B | $4.03B | $4.00B | $3.96B | $3.90B | $3.87B | $3.91B | $3.84B |
| Net debt | $6.74B | $6.61B | $6.51B | $6.80B | $6.72B | $6.75B | $6.85B | $7.11B |
| Cash flow statement | ||||||||
| Operating cash flow | $200.00M | $99.00M | $516.00M | $224.00M | $259.00M | $135.00M | $512.00M | $225.00M |
| Capital expenditure | $64.00M | $70.00M | $100.00M | $127.00M | $130.00M | $85.00M | $101.00M | $110.00M |
| Free cash flow | $136.00M | $29.00M | $416.00M | $97.00M | $129.00M | $50.00M | $411.00M | $115.00M |
| Investing cash flow | -$59.00M | -$64.00M | -$97.00M | -$137.00M | -$107.00M | $95.00M | -$128.00M | -$47.00M |
| Financing cash flow | -$147.00M | -$194.00M | -$27.00M | -$51.00M | -$164.00M | -$915.00M | -$363.00M | $523.00M |
| Depreciation & amortization | $107.00M | $105.00M | $102.00M | $99.00M | $106.00M | $109.00M | $110.00M | $109.00M |
| Stock-based compensation | $8.00M | $15.00M | $20.00M | $13.00M | $5.00M | $16.00M | $17.00M | $19.00M |
| Dividends paid | $116.00M | $117.00M | $117.00M | $120.00M | $116.00M | $116.00M | $111.00M | $116.00M |
| Share buybacks | $0 | $0 | $2.00M | $24.00M | $2.00M | $4.00M | $2.00M | $54.00M |
Free plan shows the latest 8 periods; Pro shows all 72 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.